Regeneron and Sanofi Treat First Person Outside U.S. in Coronavirus-Drug Trial

Regeneron and Sanofi said they'd treated the first patient outside the U.S. in a trial, within a global clinical program, of a drug designed to treat patients hospitalized with severe Covid-19.